Dr. Ethan Balkin

Dr. Balkin is responsible for all radioisotope R&D conducted within the DOE Isotope Program. Prior to joining DOE, Dr. Balkin was a Professor at the University of Washington-Seattle, where he worked on solid target chemistry for the production of the cyclotron-based isotopes, as well as bioconjugation and radiolabeling techniques for monoclonal antibodies and small molecules. He also did his postdoctoral training there.

Dr. Balkin completed his undergraduate work with a research focus in radioanalytical chemistry, and his doctorate in pathobiology with an emphasis in targeted radiopharmaceutical therapy and rational drug design; both at the University of Missouri-Columbia. In between his undergraduate and graduate work, Dr. Balkin spent two years working in drug development focusing on critical-care pediatrics at the University of Missouri-Columbia Department of General Surgery.